• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

Archive by Topic » News

Therapeutic Plasma Exchange in Patients with Severe COVID-19

Many patients with severe COVID-19 deteriorate rapidly when their immune systems become hyperactive, also known as cytokine storm.  No effective…

July 1, 2020

ABO Blood Group Associated with COVID-19 Severity

It has long been known that different blood antigens may carry risks or protection depending on the disease, and coronaviruses…

June 23, 2020

Pathogen Reduction Reduces SARS-CoV-2 in Plasma and Whole Blood

Similar to other respiratory viruses, it is suspected that SARS-CoV-2 is not transfusion-transmitted.  Nevertheless, SARS-CoV-2 has been detected in plasma,…

June 17, 2020

Physical Distancing and PPE Reduce Transmission of SARS-CoV-2

The transfusion medicine community staff are at risk of SARS-CoV-2 transmission; both laboratory technologists in the hospital and staff at…

June 10, 2020

COVID-19 Pandemic Impact on Transfusion Services: Elective Surgeries Resume, Convalescent Plasma Use Increases, and Blood Supply Drops to Critical Levels

Based on the AABB COVID-19 Weekly Hospital Transfusion Survey, which collected data from 96 hospitals in 35 states between May…

June 2, 2020

Convalescent Plasma Decreases Mortality for Non-Intubated Patients with Severe COVID-19

Based on a preliminary propensity score-matched control study, convalescent plasma is beneficial for non-intubated patients with severe COVID-19. At the…

May 27, 2020

Convalescent Plasma for COVID-19 Safe in First 5,000 Patients

With limited therapies for patients with COVID-19 and a mortality rate of approximately 50% for patients in the ICU, demand…

May 19, 2020

Coagulopathy in Patients with COVID-19—Interim Guidance from the International Society on Thrombosis and Haemostasis

Although the pathophysiology of severe COVID-19 is poorly understood, coagulopathy near the lungs has been shown to play an important…

May 13, 2020

Blood Product Recalls Strain Finite Resources

With blood shortage concerns from the COVID-19 pandemic, blood products are now more than ever a precious commodity.  A recent…

May 6, 2020

SARS-CoV-2 Antibody Titers and Qualifying Donors for Convalescent Plasma

With no vetted therapies or vaccines for COVID-19 and almost a million confirmed cases in the United States alone, the…

April 29, 2020

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 24
  • Page 25
  • Page 26
  • Page 27
  • Page 28
  • Interim pages omitted …
  • Page 61
  • Go to Next Page »

Primary Sidebar

Latest News

  • New Erythropoietin Gene Variants Linked to Hereditary Erythrocytosis

  • Multifaceted Threats to the Blood Supply from Climate Change

  • Distinct Roles for Differently Aged Platelets

  • Anemia Treatment Bundle Improves Hemoglobin Recovery after Critical Illness

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley